Daniel Leuenberger

Title: The Innovative Contributions of Daniel Leuenberger

Introduction

Daniel Leuenberger is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of crystalline forms of various compounds. With a total of 3 patents to his name, Leuenberger's work has the potential to impact medical treatments significantly.

Latest Patents

One of Leuenberger's latest patents involves crystalline forms of 4-((R)-2-{[6-((S)-3-methoxy-pyrrolidin-1-yl)-2-phenyl-pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1-carboxylic acid butyl ester hydrochloride. This invention details processes for the preparation of these crystalline forms, pharmaceutical compositions that include them, and their use as a medicament, particularly as a P2Y receptor antagonist. This innovative approach could lead to advancements in therapeutic applications.

Career Highlights

Throughout his career, Daniel Leuenberger has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Idorsia Pharmaceuticals Ltd and Viatris Asia Pacific Ptd. Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development.

Collaborations

Leuenberger has collaborated with esteemed colleagues such as Stefan Reber and Markus Von Raumer. These partnerships have likely enhanced his innovative capabilities and contributed to the success of his projects.

Conclusion

Daniel Leuenberger's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and showcases the importance of innovation in the industry.